Particle.news
Download on the App Store
3 ARTICLES
·
4w ago

Mayo Clinic Validates AI Tools for Preconception Cardiac Screening in Women

High-performing AI technologies detect heart muscle weakness in women of reproductive age, paving the way for early intervention and improved maternal health outcomes.

Image

Overview

  • Mayo Clinic researchers demonstrated that AI-driven ECG and digital stethoscope tools can accurately detect left ventricular ejection fraction below 50% in women aged 18 to 49.
  • The study, involving 200 women across two cohorts, revealed diagnostic accuracy with an AUC of 0.94 for the AI-ECG and 0.98 for the Eko DUO digital stethoscope.
  • Positive screening rates in routine primary care were 1% for the AI-ECG and 3.2% for the AI-stethoscope, reflecting the tools' potential for broader clinical use.
  • Licensing agreements with EKO Health and Anumana signal imminent clinical adoption, with revenue supporting Mayo Clinic's nonprofit mission.
  • Further research is underway to assess the applicability of these AI tools in more diverse populations, aiming to modernize maternal healthcare and reduce cardiac-related mortality.